Neuro-oncology: What is the optimal use of bevacizumab in glioblastoma?
Publication
, Journal Article
Desjardins, A
Published in: Nat Rev Neurol
August 2015
Duke Scholars
Published In
Nat Rev Neurol
DOI
EISSN
1759-4766
Publication Date
August 2015
Volume
11
Issue
8
Start / End Page
429 / 430
Location
England
Related Subject Headings
- Quality of Life
- Neurology & Neurosurgery
- Male
- Humans
- Glioblastoma
- Female
- Drug Costs
- Dacarbazine
- Chemoradiotherapy
- Brain Neoplasms
Citation
APA
Chicago
ICMJE
MLA
NLM
Desjardins, A. (2015). Neuro-oncology: What is the optimal use of bevacizumab in glioblastoma? Nat Rev Neurol, 11(8), 429–430. https://doi.org/10.1038/nrneurol.2015.127
Desjardins, Annick. “Neuro-oncology: What is the optimal use of bevacizumab in glioblastoma?” Nat Rev Neurol 11, no. 8 (August 2015): 429–30. https://doi.org/10.1038/nrneurol.2015.127.
Desjardins A. Neuro-oncology: What is the optimal use of bevacizumab in glioblastoma? Nat Rev Neurol. 2015 Aug;11(8):429–30.
Desjardins, Annick. “Neuro-oncology: What is the optimal use of bevacizumab in glioblastoma?” Nat Rev Neurol, vol. 11, no. 8, Aug. 2015, pp. 429–30. Pubmed, doi:10.1038/nrneurol.2015.127.
Desjardins A. Neuro-oncology: What is the optimal use of bevacizumab in glioblastoma? Nat Rev Neurol. 2015 Aug;11(8):429–430.
Published In
Nat Rev Neurol
DOI
EISSN
1759-4766
Publication Date
August 2015
Volume
11
Issue
8
Start / End Page
429 / 430
Location
England
Related Subject Headings
- Quality of Life
- Neurology & Neurosurgery
- Male
- Humans
- Glioblastoma
- Female
- Drug Costs
- Dacarbazine
- Chemoradiotherapy
- Brain Neoplasms